PerkinElmer Establishes Wholly Owned Subsidiary in India
PerkinElmer, Inc. announced that it has acquired the remaining minority interest in PerkinElmer India Pvt. Ltd., a direct sales, service and marketing operation targeting India's life science and analytical instrumentation markets, from Labindia Instruments Pvt. Ltd. The transaction establishes PerkinElmer India Ltd. as a wholly owned subsidiary of PerkinElmer.
"The establishment of a 100% direct operation in India demonstrates our continued commitment to accelerate growth in the country's rapidly expanding health sciences market," said Gregory L. Summe, PerkinElmer chairman and chief executive officer. "Customers in the region will benefit from an increased level of applications and technical support, as well as direct access to a wider range of PerkinElmer products. A stronger India presence will enable us to react faster to changing needs and develop new solutions specifically for the market."
India represents a key market for PerkinElmer, with significant growth opportunities in areas including pharmaceutical research, neonatal and maternal screening, and environmental monitoring. To further support its growth in the region, PerkinElmer plans to open a new India headquarters in Mumbai, as well as a new technical support and applications center in the second half of 2007. PerkinElmer India currently employs approximately 170 people in Bangalore, Baroda, Chennai, Hyderabad, Kolkatta, Mumbai, New Delhi, Pune and Thane.
PerkinElmer also announced the appointment of Jai Shankar as president, PerkinElmer India. Shankar will be responsible for setting the strategic direction of PerkinElmer's business development activities across India and overseeing the expansion of PerkinElmer's broad product and services portfolio to the country's growing community of scientists and researchers.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Evolving viruses to fight bacterial infections
Watching atoms and electrons at work
Evotec Signs Agreement with DiscoveRx Corporation to Support High Throughput Screening Services
New x-ray method for Corona diagnosis ready for patient testing - Low-dose radiographs could reveal typical lung changes
Dako and Epitomics enter into strategic alliance on developing and launching IHC diagnostic monoclonal antibodies
Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets
Sales growth fuels Freeman Technology expansion into new HQ
First field measurements of laughing gas isotopes - Greenhouse gas emissions from soil
Carbon Nanotubes: Endless Opportunities
Sartorius expects profitable growth in 2024 - Double-digit annual sales revenue growth projected through to 2028